Linagliptin impurity KH-3
|
|
|
- CAS-Nr.
- 2279114-27-9
- Englisch Name:
- Linagliptin impurity KH-3
- Synonyma:
- Linagliptin impurity KH-3;tert-butyl (R)-(1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn- 1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3- yl)carbamate;Carbamic acid, N-[(3R)-1-[1-[2-[(2-acetylphenyl)amino]-2-oxoethyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester;(R)-tert-Butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate (Linagliptin Impurity)
- CBNumber:
- CB29019883
- Summenformel:
- C30H37N7O6
- Molgewicht:
- 591.66
- MOL-Datei:
- 2279114-27-9.mol
|
Linagliptin impurity KH-3 Eigenschaften
- Dichte
- 1.31±0.1 g/cm3(Predicted)
- pka
- 12.13±0.20(Predicted)
Sicherheit
Linagliptin impurity KH-3 Chemische Eigenschaften,Einsatz,Produktion Methoden
Linagliptin impurity KH-3 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Linagliptin impurity KH-3 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 18)Lieferanten
- Linagliptin impurity KH-3
- tert-butyl (R)-(1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn- 1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3- yl)carbamate
- (R)-tert-Butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate (Linagliptin Impurity)
- Carbamic acid, N-[(3R)-1-[1-[2-[(2-acetylphenyl)amino]-2-oxoethyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 2279114-27-9
